For US residents only.

For Patients With Acromegaly

Sandostatin® LAR Depot

Important Safety Information:

Warnings and Precautions: Treatment with Sandostatin LAR Depot may affect gallbladder function, sugar metabolism, thyroid and heart function, and nutritional absorption, which may require monitoring b...

See More
Approved Use:

Sandostatin® LAR Depot (octreotide acetate for injectable suspension) is indicated for patients in whom initial treatment with immediate release Sandostatin® (octreotide acetate) Injection has been shown to be effective and tolerated for:

  • Long-term maintenance therapy in acromegalic pa...
See More
learn more about

Sandostatin® LAR Depot

Sandostatin® LAR Depot (octreotide acetate for injectable suspension) is a medical treatment for acromegaly in patients who have responded and tolerated Sandostatin® Injection (octreotide acetate). Both Sandostatin® LAR Depot and Sandostatin® Injection (octreotide acetate) are known as somatostatin analogues, and may reduce both growth hormone (GH) and insulin-like growth factor-1 (IGF-1) levels.

Learn More
learn more about

Acromegaly

The term "acromegaly" comes from the Greek words "acro" (extremities) and "megaly" (enlargement). As the name suggests, acromegaly can be recognized by abnormal growth of the hands and feet, as well as other signs such as enlargement of the facial features. However, acromegaly also involves changes in the way the body functions. These health risks make it important to attain and maintain control of the condition once it has been diagnosed.

Learn More